Guardian Pharmacy Services, Inc. (GRDN)

GRDN Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,327	1,228	1,046	908.91	792.07	735.96
Revenue Growth (YoY)	18.53%	17.42%	15.10%	14.75%	7.63%	5.39%
Cost of Revenue	1,066	984.04	837.88	723.04	630.81	588.96
Gross Profit	260.48	244.37	208.31	185.87	161.27	147
Selling, General & Admin	318.25	302.85	143.91	133.88	118.09	102.54
Operating Expenses	318.25	302.85	143.91	133.88	131.12	114.05
Operating Income	-57.77	-58.48	64.4	51.99	30.15	32.95
Interest Expense	-1.79	-3.28	-2.86	-1.93	-1.64	-2.16
Other Non Operating Income (Expenses)	0.34	-0.28	-0.37	-0.4	-0.19	-0.25
EBT Excluding Unusual Items	-59.22	-62.04	61.17	49.66	28.33	30.54
Merger & Restructuring Charges	-	-	-	-	-	-0.25
Other Unusual Items	8.91	-4.44	-23.45	-	-	-0.64
Pretax Income	-50.32	-66.48	37.72	49.66	28.33	29.66
Income Tax Expense	12.15	4.56	-	-	-	-
Earnings From Continuing Operations	-62.47	-71.03	37.72	49.66	28.33	29.66
Minority Interest in Earnings	-6.34	-16.25	-13.82	-14.24	-12.01	-9.72
Net Income	-68.81	-87.29	23.9	35.42	16.31	19.94
Preferred Dividends & Other Adjustments	22.76	22.76	23.9	-	-	-
Net Income to Common	-91.57	-110.05	-	35.42	16.31	19.94
Net Income Growth	-	-	-32.52%	117.12%	-18.20%	-8.29%
Shares Outstanding (Basic)	62	62	-	-	-	-
Shares Outstanding (Diluted)	62	62	-	-	-	-
EPS (Basic)	-1.47	-1.77	-	-	-	-
EPS (Diluted)	-1.47	-1.77	-	-	-	-
Free Cash Flow	37.92	41.59	56.26	31.75	49.22	44.27
Free Cash Flow Per Share	0.61	0.67	-	-	-	-
Gross Margin	19.63%	19.89%	19.91%	20.45%	20.36%	19.97%
Operating Margin	-4.35%	-4.76%	6.16%	5.72%	3.81%	4.48%
Profit Margin	-6.90%	-8.96%	-	3.90%	2.06%	2.71%
Free Cash Flow Margin	2.86%	3.39%	5.38%	3.49%	6.21%	6.02%
EBITDA	-36.87	-38.71	82.63	68.55	46.68	50.2
EBITDA Margin	-2.78%	-3.15%	7.90%	7.54%	5.89%	6.82%
D&A For EBITDA	20.9	19.77	18.23	16.56	16.53	17.26
EBIT	-57.77	-58.48	64.4	51.99	30.15	32.95
EBIT Margin	-4.35%	-4.76%	6.16%	5.72%	3.81%	4.48%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q